1. Home
  2. ABUS vs YELP Comparison

ABUS vs YELP Comparison

Compare ABUS & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.69

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Yelp Inc.

YELP

Yelp Inc.

HOLD

Current Price

$18.24

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABUS
YELP
Founded
2005
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2008
2011

Fundamental Metrics

Financial Performance
Metric
ABUS
YELP
Price
$4.69
$18.24
Analyst Decision
Strong Buy
Hold
Analyst Count
1
6
Target Price
$5.00
★ $29.17
AVG Volume (30 Days)
★ 4.7M
1.2M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 55.26
19.15
EPS
0.84
★ 0.86
Revenue
$14,083,000.00
★ $1,464,955,000.00
Revenue This Year
N/A
$2.19
Revenue Next Year
$239.71
$2.34
P/E Ratio
★ $5.71
$20.67
Revenue Growth
★ 128.21
3.75
52 Week Low
$3.50
$17.27
52 Week High
$5.45
$34.49

Technical Indicators

Market Signals
Indicator
ABUS
YELP
Relative Strength Index (RSI) 37.59 28.56
Support Level $4.42 N/A
Resistance Level $4.81 $24.91
Average True Range (ATR) 0.09 0.73
MACD -0.05 -0.19
Stochastic Oscillator 16.48 10.52

Price Performance

Historical Comparison
ABUS
YELP

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.

Share on Social Networks: